In the BioHarmony Drug Report Database

"Preview" Icon

Hydroxyprogesterone caproate

Delalutin, Hydroxyprogesterone Caproate, Makena (hydroxyprogesterone caproate) is a small molecule pharmaceutical. Hydroxyprogesterone caproate was first approved as Delalutin on 1982-01-01. Makena’s patents are valid until 2036-05-02 (FDA).

 

Trade Name

 

Delalutin, Hydroxyprogesterone Caproate, Makena
 

Common Name

 

hydroxyprogesterone caproate
 

ChEMBL ID

 

CHEMBL1200848
 

Indication

 

 

Drug Class

 

Progestins; steroids (androgens, anabolics)

Image (chem structure or protein)

Hydroxyprogesterone caproate structure rendering